Kota Tachibana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kota Tachibana has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Ai Miyamoto
Graduate School of Interdisciplinary Science and Engineering in Health Systems Okayama University Okayama Japan
28 shared publications - Fumiaki Mukohara
Department of Tumor Microenvironment, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan
28 shared publications - Hidetaka Yamamoto
Department of Pathology and Oncology, Graduate School of Medicine, Dentistry & Pharmaceutical Science Okayama University Okayama Japan
28 shared publications - Hidetoshi Hayashi
Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan
28 shared publications - Isamu Okamoto
Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
28 shared publications - Joji Ishida
Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
28 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
Gating strategy for T cells in flow cytometry analysis
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
Gating strategy for T cells in flow cytometry analysis
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S8 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
TFH cells in intracranial TILs from CD4-cre/Bcl6fl/fl mice
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
TFH cells in intracranial TILs from CD4-cre/Bcl6fl/fl mice
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S9 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
Additional TIL data related to myeloid-B-TFH cell axis
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
Additional TIL data related to myeloid-B-TFH cell axis
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
B16F10 TIL data related to CTLA-4+ T cell subsets
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
B16F10 TIL data related to CTLA-4+ T cell subsets
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
Gating strategy for myeloid cells in flow cytometry analysis
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
Gating strategy for myeloid cells in flow cytometry analysis
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
Additional data related the effects of anti-PD-1 and anti-CTLA-4 mAbs on TILs
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
Additional data related the effects of anti-PD-1 and anti-CTLA-4 mAbs on TILs
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S11 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
TLS in brain metastases of patients with NSCLC, and B and plasma cell cluster in the murine intracranial TME
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S11 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
TLS in brain metastases of patients with NSCLC, and B and plasma cell cluster in the murine intracranial TME
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
Gating strategy for B cells and plasma cells in flow cytometry analysis
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
Gating strategy for B cells and plasma cells in flow cytometry analysis
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
Additional LL/2 TIL data related to CTLA-4+ T cell subsets
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
Additional LL/2 TIL data related to CTLA-4+ T cell subsets
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
Clinical courses and additional in vivo efficacy data
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy
Clinical courses and additional in vivo efficacy data